Search Results
Aug 07, 2026, 07:00 ET Calumet Reports Second Quarter 2026 Results
regarding our business outlook and cash flows, including with respect to the Montana Renewables business and our plans to de-leverage our balance sheet, (iii) our ability to monetize federal clean fuel production tax credits ("CFPCs") under Section 45Z of the Internal Revenue Code and the price we expect to
More news about: Calumet, Inc.
Aug 07, 2026, 06:34 ET Alebund's AP301 NDA Accepted for Review by China's NMPA
tolerability, and enhanced patient adherence.AP301 China Pivotal Phase III Trial (RESPOND-1)RESPOND-1 was a randomized, open-label, active-controlled, multicenter pivotal Phase III clinical trial conducted at 50 sites in China and led by Professor Li Zuo,
More news about: Alebund Pharmaceuticals
Aug 07, 2026, 06:15 ET Trulieve Reports Second Quarter 2026 Results
register state licensed medical marijuana operations with the Drug Enforcement Agency following federal rescheduling of medical marijuana to Schedule III.Completed deconsolidation of Harvest mixed medical and adult use state operations.Listed on the New York Stock Exchange under ticker
More news about: Trulieve Cannabis Corp.
Aug 07, 2026, 06:00 ET Century Casinos, Inc. Announces Second Quarter 2026 Results
includes the Century Casinos & Hotels in Cape Girardeau and Caruthersville, Missouri, and in Cripple Creek and Central City, Colorado; (iii) US West includes the Nugget Casino Resort in Reno-Sparks, Nevada; (iv) Canada includes Century Casino & Hotel in Edmonton,
More news about: Century Casinos, Inc.
Aug 07, 2026, 05:45 ET MDA SPACE REPORTS SECOND QUARTER 2026 RESULTS
We define EBITDA as net income (loss) before: i) depreciation and amortization expenses, ii) provision for (recovery of) income taxes, and iii) finance costs. Adjusted EBITDA is calculated by adding to and deducting from EBITDA, as applicable, certain expenses, costs, charges or benefits incurred
More news about: MDA Space
Aug 07, 2026, 02:44 ET Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
Yochanra®. Meanwhile, for cholangiocarcinoma, enrollment has been completed in the global multicenter registrational Phase III study of Yochanra®, while the Phase III confirmatory study in China is progressing in parallel. For other indications, the Company will continue to advance clinical
More news about: TransThera Sciences (Nanjing) Inc.
Aug 06, 2026, 21:58 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
joining the class action]On April 29, 2026, during during Regeneron's first quarter earnings call, the Company disclosed that the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for "analysis of progression-free survival." On
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT
for a $40,000 fine and a three-year ban from participating in a penny stock offering. Nor did the Company's announcement disclose that Edward Withrow III ("Withrow"), an individual listed as inventor alongside Defendant Bradley on multiple Data Vault Holdings patents, had a previous felony conviction for
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Intuit Inc. and Certain Officers - INTU
marketing products and services in the United States. The Company has four reportable business segments: (i) Global Business Solutions; (ii) Consumer; (iii) Credit Karma; and (iv) ProTax. Intuit's Consumer segment provides do-it-yourself ("DIY") and assisted income tax preparation products and services under
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD
heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The truth began to emerge on March 12,
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against First Solar, Inc. and Certain Officers - FSLR
and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The truth began to emerge on January 7,
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers - NNOX
demand for its products; (ii) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against BitGo Holdings, Inc. and Certain Officers - BTGO
Defendants' statements regarding, inter alia, BitGo's financial performance and business prospects as a public company lacked a reasonable basis; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Microvast Holdings, Inc. and Certain Officers - MVST
ability to reach its margin targets; (ii) Defendants overstated Microvast's ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The market received its first inkling of
More news about: Pomerantz LLP
Aug 06, 2026, 19:59 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Wix.com Ltd. and Certain Officers - WIX
relative to those offered by other companies; (ii) Wix had understated the costs associated with developing and promoting its AI product offerings; (iii) accordingly, Defendants overstated the commercial and financial benefits of Wix's AI product offerings; and (iv) as a result, Defendants' public statements
More news about: Pomerantz LLP
Aug 06, 2026, 19:00 ET Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU
strategy.Phase III Development and Taiwan Registration PathwayENERGI-F703DFU is currently being evaluated in a Phase III clinical trial (NCT05930210) in Taiwan and the United States. Subject to continued recruitment progress, Energenesis expects to complete Phase III patient enrollment
More news about: Energenesis Biomedical Co., Ltd.
Aug 06, 2026, 17:01 ET Sun Life Reports Second Quarter 2026 Results
actionsOther adjustments:i) MFS shares owned by managementii) Acquisition, integration, and restructuringiii) Intangible asset amortizationiv) Other items that are unusual or exceptional in natureFor more details about the adjustments removed
More news about: Sun Life Financial Inc. - Financial News
Aug 06, 2026, 17:01 ET Sun Life Reports Second Quarter 2026 Results
actionsOther adjustments:i) MFS shares owned by managementii) Acquisition, integration, and restructuringiii) Intangible asset amortizationiv) Other items that are unusual or exceptional in natureFor more details about the adjustments removed
More news about: Sun Life Financial Inc. - Financial News
Aug 06, 2026, 17:00 ET DVLT Investors with Losses in Excess of $100K Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit
overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (3) Datavault's undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (4) as a result, defendants' public statements were materially
More news about: THE ROSEN LAW FIRM, P. A.
Aug 06, 2026, 17:00 ET Wheaton Precious Metals Announces Second Quarter 2026 Results and Record Year-to-Date Production, Revenue, Earnings and Cash Flow
3)Refer to discussion on non-GAAP measure (iii) at the end of this press release.4)
More news about: Wheaton Precious Metals Corp.
Aug 06, 2026, 16:31 ET Old Slip's Fraudulent-Inducement Claim Against Allstate Survives Summary Judgment and Advances Toward Jury Trial
investment advisory business; (ii) Old Slip Benefits & Insurance Services, LLC, a licensed insurance agency, and the plaintiff in this action; and (iii) Old Slip Capital Management, Inc., a mutual fund retailer and broker-dealer.Case InformationOld Slip Benefits & Insurance
More news about: Old Slip Capital Partners
Aug 06, 2026, 16:20 ET MSC INCOME FUND ANNOUNCES SECOND QUARTER 2026 RESULTS
ending accrual for the accrued capital gains incentive fee(3) as of June 30, 2026, (ii) a $1.2 million increase in interest expense and (iii) a $0.4 million increase in base management fees, partially offset by a $0.6 million decrease in incentive fee on income, net of waivers. The increase
More news about: MSC Income Fund, Inc.
Aug 06, 2026, 16:15 ET Drilling Tools International Corp. Reports 2026 Second Quarter Results
depreciation and amortization, further adjusted for (i) goodwill and/or long-lived asset impairment charges, (ii) stock-based compensation expense, (iii) restructuring charges, (iv) transaction and integration costs related to acquisitions and (v) other expenses or charges to exclude certain items that
More news about: Drilling Tools International Corp.
Aug 06, 2026, 16:15 ET Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
to the Exchange Offers and Consent Solicitations or the Separation, including the receipt of the Requisite Consents, may not be satisfied or waived; (iii) that any event, change or other circumstance could give rise to the termination of the Exchange Offers and Consent Solicitations and/or the Separation;
More news about: Corteva Agriscience
Aug 06, 2026, 16:15 ET MATTHEWS INTERNATIONAL REPORTS RESULTS FOR FISCAL 2026 THIRD QUARTER
performance using the same tools that management uses to budget, forecast, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company's results. The Company's calculations of its non-GAAP
More news about: Matthews International Corporation